|Table of Contents|

Comparison of chronic atrophic gastritis by endoscopy and the pathological results

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2018 06
Page:
899-902
Research Field:
Publishing date:

Info

Title:
Comparison of chronic atrophic gastritis by endoscopy and the pathological results
Author(s):
Pan DuoSun SiyuLiu XiangWang ShengGe NanWang GuoxinGuo Jintao
Endoscopy Center of Shengjing Hospital of China Medical University,Liaoning Shenyang 110004,China.
Keywords:
chronic atrophic gastritismucosal biopsyintestinal metaplasiaatypical hyperplasiaintraepithelial neoplasia
PACS:
R735.2
DOI:
10.3969/j.issn.1672-4992.2018.06.020
Abstract:
Objective:To compare the results of chronic atrophic gastritis by endoscopy and the pathological results by mucosal biopsy.Explore their consistency and clinical significance.Methods:Collect 67 727 patients from July 2013 to July 2016 in the endoscopy center of our hospital.2 484 patients of 67 727 patients were chronic atrophic gastritis by endoscopy.Compare their consistency of the results of chronic atrophic gastritis by endoscopy and the pathological results by mucosal biopsy.Results:38 patients refused to do pathological diagnosis,1 196 patients of chronic superficial gastritis,1 250 patients of chronic atrophic gastritis,322 patients with intestinal metaplasia,108 patients with atypical hyperplasia,218 patients with intraepithelial neoplasia.The accuracy rate of gastroscopy in the diagnosis of atrophic gastritis was 50.32%.Endoscopic manifestations showed mucosal roughness,granular or nodular changes in the pathology coincidence rate of 32.59%.Endoscopic findings showed endoscopic mucosal roughness,granular or nodular changes,mucosal red and white,white to the main pathology of the rate of 23.40%,the coincidence rate between the difference was not statistically significant(P> 0.05).Endoscopic manifestations showed mucosal roughness,granular or nodular changes,mucosal red and white,white-based,mucosal vascular exposure and transparent visible folds thinning,flatten or disappear the pathology coincidence rate of 83.77 %.There was significant difference between the coincidence rates(P<0.05).Conclusion:There is difference between the results of chronic atrophic gastritis by endoscopy and the pathological results by mucosal biopsy.In order to improve the accuracy,endoscopy should combine with the chronic atrophic gastritis performance characteristics.To avoid missed diagnosis,endoscopy with mucosal biopsy can achieve the goals of active prevention and early discovery.

References:

[1]Li WJ.Endoscopic diagnosis of chronic gastritis a clinical analysis and pathological diagnosis[J].China Modern Doctor,2010,48(32):140-141.
[2]Marqu S-Lespier JM,Gonz Lez-Pons M,Cruz-Correa M.Current perspectives on gastric cancer[J].Gastroenterol Clin North Am,2016,45(3):413-428.
[3]Siegel RL,Miller KD,Jemal A.Cancer statistics,2016[J].CA Cancer J Clin,2016,66(1):7-30.
[4]Shitara K,Ohtsu A.Advances in systemic therapy for metastatic or advanced gastric cancer[J].J Natl Compr Canc Netw,2016,14(10):1313-1320.
[5]Li CQ,Li Y,Zuo XL,et al.Magnified and enhanced computed virtual chromoendoscopy in gastric neoplasia:A feasibility study[J].World J Gastroenterol,2013,19(26):4221-4227.
[6]Zhang L,Hou Y,Wu K,et al.Comparative proteomies analysis of chronic atrophic gastritis:Changes of protein expression in chronic atrephie gastritis without Helicobacter pylori infection[J].Braz J Med Biol Res,2012,45(3):273-283.
[7]Peek RM Jr,Blaser MJ.Helieobaeter pylori and gastrointestinal tract adenocarcinomas[J].Nat Rev Cancer,2002,2(1):28-37.
[8]Peng Xiaobo,Yan Fang,Wang Bin,et al.Docetaxel and oxaliplatin plus S-1 versus S-1 plus oxaliplatin for the treatment of advanced gastric cancer(AGC)[J].Modern Oncology,2015,23(1):88-91.
[9]Han B,Jung JY,Kim HS,et al.A dose-finding study for oxaliplatin,irinotecan,and S-1(OIS) in patients with metastatic or recurrent gastrointestinal cancer[J].Cancer Chemother Pharmacol,2016,78(5):949-958.
[10]Jing JJ,Liu HY,Hao JK,et al.Gastric cancer incidence and mortality in Zhuanghe,China,between 2005 and 2010[J].World J Gastroenterol,2012,18(11):1262-1269.
[11]Wang SM,Tie J,Wang WL,et al.POU2F2-oriented network promotes human gastric cancer metastasis[J].Gut,2016,65(9):1427-1438.
[12]Fan Jinhe,Qian Junbo,Zang Hong,et al.Dignosis value of magnifyingchromogastrocopy in early gastric cancer and precancerous lesions[J].China Journal of Endoscopy,2011,17(4):351-353.
[13]Kikuste I,Marques-Pereira R,Monteiro-Soares M,et al.Systematic reviewof the diagnosis of gastric premalignant conditions and neoplasia with high-resolution endoscopic technologies[J].Scand J Gastroenterol,2013,48(10):1108-1117.
[14]Shihmin Hsia,Chengchia Yu,Shih YH,et al.Isoliquiritigenin as a cause of DNA damage and inhibitor of ataxia-telangiectasia mutated expression leading to G2/M phase arrest and apoptosis in oral squamous cell carcinoma[J].Head & Neck,2015,16(7):2929-2937.
[15]Wang Z,Zhang X,Hu J,et al.Clinicopathological features and outcomes in patients undergoing radical resection for early gastric cancer with signet ring cell histology[J].J Visc Surg,2015,152(6):357-361.
[16]Butler LM,Zhou X,Xu WS,et al.The histone deacetylase inhibitor SAHA arrests cancer cell growth,up-regulates thioredoxin-binding protein-2,and down-regulates thioredoxin[J].Proc Natl Acad Sci USA,2002,99(18):11700-11705.
[17]Subramanian V,Ragunath K.Advanced endoscopic imaging:A review of commercially available technologies[J].Clin Gastroenterol Hepatol,2013,28:S1542-3565.
[18]Chang X,Xu X,Xue X,et al.NDRG1 controls gastric cancer migration and invasion through regulating MMP-9[J].Pathol Oncol Res,2016,22(4):789-796.
[19]Weck MN,Brenner H.Prevalence of chronic atrophic gastritis in different parts of the world[J].Cancer Epidemiology,Biomarkers & Prevention,2006,15(6):1083-1094.
[20]Zhang L,Li N,Wu K,et al.Effect of PSME1 gene on biological charac?tefistics of human gastric adenocarcinoma cell line SGC-7901 in vitro[J].Chin J Gastroenterol,2010,15(4):229-232.
[21]Peng Z,Zhang Y.Propofol inhibits proliferation and accelerates apoptosis of human gastric cancer cells by regulation of microRNA-451 and MMP-2 expression[J].Genetics and Molecular Research:GMR,2016,15(2):15027078.
[22]Ramakrishnan S,Ku S,Ciamporcero E,et al.HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma[J].BMC Cancer,2016,16:617.
[23]Palma CS,Grassi ML,Thome CH,et al.Proteomic analysis of epithelial to mesenchymal transition(EMT) reveals cross-talk between SNAIL and HDAC1 proteins in breast cancer cells[J].Molecular & Cellular Proteomics,2016,15(3):906-917.
[24]Pittayanon R,Rerknimitr R.Role of digital chromoendoscopy and confocal laser endomicroscopy for gastric intestinal metaplasia and cancer surveillance[J].World J Gastrointest Endosc,2012,4(10):472-478.
[25]Ma HW,Xia ZY,Zhao B,et al.Effect of propofol on the invasiveness of HGC-27 gastric cancer cells[J].Chin J Gastroenterol and Hepatol,2016,25(6):623-625.[马浩文,夏中元,赵博,等.异丙酚对胃癌HGC-27细胞侵袭能力的影响[J].胃肠病学和肝病学杂志,2016,25(6):623-625.]
[26]Liu ZH,Li J,Xia J,et al.Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells[J].Chemico-Biological Interactions,2015,242:227-234.
[27]Rios-Castellanos E,Sitas F,Shepherd NA,et al.Changing pattern of gastric cancer in Oxfordshire[J].Gut,1992,33(10):1312-1317.
[28]Shang FT,Hui LL,An XS,et al.ZnPPIX inhibits peritoneal metastasis of gastric cancer via its antiangiogenic activity[J].Biomed Pharmacother,2015,71(1):240-246.
[29]Shao Y,Ye M,Li Q,et al.LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer[J].Oncotarget,2016,7(25):37812-37824.
[30]Huang YK,Yu JC.Circulating micro RNAs and long non-coding RNAs in gastric cancer diagnosis:An update and review[J].World J Gastroenterol,2015,21(34):9863-9886.
[31]Kwon HJ,Won YS,Suh HW,et al.Vitamin D3 upregulated protein 1 suppresses TNF-d-induced NF-KB activation in hepatocareinogenesis[J].J Immunol,2010,185(7):3980-3989.
[32]Zhang M,Du X.Noncoding RNAs in gastric cancer:Research progress and prospects[J].World Journal of Gastroenterology,2016,22(29):6610-6618.
[33]Zhou P,Jiang N,Zhang GX,et al.miR-203 inhibits tumor invasion and metastasis in gastric cancer by ATM[J].Acta Biochimica et Biophysica Sinica,2016,48(8):696-703.

Memo

Memo:
-
Last Update: 2018-01-29